Palisade Bio (PALI) Return on Sales (2011 - 2023)

Palisade Bio (PALI) has 12 years of Return on Sales data on file, last reported at 1.95% in Q4 2023.

• On a quarterly basis, Return on Sales changed N/A year-over-year to 1.95% in Q4 2023; TTM through Dec 2023 was 1.95%, a N/A change from a year earlier, with the FY2023 full-year figure at 1.68%, changed N/A from the prior year.
• Return on Sales for Q4 2023 stood at 1.95%, up from 1.98% in the prior quarter.
• Over the last five years, Return on Sales for PALI reached as high as 1.53% in Q1 2023 and fell as low as 73.71% in Q3 2022.
• Historically, Return on Sales has averaged 15.94% across 4 years, with a median of 7.6% in 2020.
• Across the five-year window, Return on Sales plunged 515 bps in 2020 and surged 7173 bps in 2023, its largest moves.
• Year by year, Return on Sales stood at 8.5% in 2019, then slumped by 53 bps to 13.02% in 2020, then sank by 466 bps to 73.71% in 2022, then soared by 97 bps to 1.95% in 2023.
• Per Business Quant data, the three most recent Return on Sales figures were 1.95% in Q4 2023, 1.98% in Q3 2023, and 2.01% in Q2 2023.